Melatonin inhibits cortical spreading depression-evoked trigeminal nociception

NeuroReport

Volumn 17, Issue 16, 2006, Pages 1709-1713

  Le Grand, Supang M ^a   Patumraj, Suthiluk ^a   Phansuwan Pujito, Pansiri ^b   Srikiatkhachorn, Anan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Cortical blood flow; Cortical spreading depression; Melatonin; Migraine; Trigeminal nociception; Trigeminal nucleus caudalis

Indexed keywords

MELATONIN; NITRIC OXIDE SYNTHASE; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN MICROCIRCULATION; CERVICAL SPINAL CORD; CONTROLLED STUDY; HYPEREMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLA OBLONGATA; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NUCLEUS;

ANIMALS; CEREBRAL CORTEX; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MELATONIN; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE; TRIGEMINAL NUCLEI;

EID: 33750306865     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3280101207     Document Type: Article

References (22)

1. Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989; 29:242-245.
2. Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S, et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994; 14:205-209.
3. Peres MFP, Sanchez del Rio M, Seabra MLV, Tufik S, Abucham J, Cipolla-Neto J, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001; 71:747-751.
4. Chazot G, Claustrat B, Brun J, Jordan D, Sassolas G, Schott B. A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache. Cephalalgia 1984; 4:213-220.
5. Waldenlind E, Gustafsson SA, Ekbom K, Wetterberg L. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50:207-213.
6. Leone M, Lucini V, D'Amico D, Moschiano F, Maltempo C, Fraschini F, Bussone G. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995; 15:224-229.
7. Peres MFP, Zukerman E, da Cunha Tanuri F, Moreira FR, Cipolla-Neto J. Melatonin, 3 mg, is effective for migraine prevention. Neurology 2004; 63:757.
8. Leone M, D'Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996; 16:494-496.
9. Capsoni S, Stankov BM, Fraschini F. Reduction of regional cerebral blood flow by melatonin in young rats. Neuroreport 1995; 19:1346-1348.
10. Regrigny O, Delagrange P, Scalbert E, Lartaud-Idjouadiene I, Atkinson J, Chillon JM. Effects of melatonin on rat pial arteriolar diameter in vivo. Br J Pharmacol 1999; 127:1666-1670.
11. Geary GG, Duckles SP, Krause DN. Effect of melatonin in the rat tail artery: role of K+ channels and endothelial factors. Br J Pharmacol 1998; 123:1533-1540.
12. Chucharoen P, Chetsawang B, Srikiatkhachorn A, Govitrapong P. Molecular and pharmacological evidence for melatonin receptor in rat cerebral artery. Neurosci Lett 2003; 341:259-261.
13. Tom B, De Vries P, Heiligers JP, Willems EW, Scalbert E, Delagrange P, Saxena PR. The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity. Cephalalgia 2001; 21:656-663.
14. Lossinsky AS, Vorbrodt AW, Wisniewski HM. Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol 1995; 24:795-806.
15. Wei EP, Dietrich WD, Povlishock JT, Navari RM, Kontos HA. Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ Res 1980; 46:37-47.
16. Hazama AF, Amano S, Ozaki T. Pathological changes of cerebral vessel endothelial cells in spontaneously hypertensive rats, with special reference to the role of these cells in the development of hypertensive cerebrovascular lesions. Adv Neurol 1978; 20:359-369.
17. Aydin NV, Caner H, Sen O, Ozen O, Ataay B, Cekinmez M, Altinors N. Effect of melatonin on cerebral vasospasm following experimental subarachnoid hemorrhage. Neurol Res 2005; 27:77-82.
18. Zou LY, Cheung RT, Liu S, Li G, Huang L. Melatonin reduces infarction volume in a photothrombotic stroke model in the wild-type but not cyclooxygenase-1-gene knockout mice. J Pineal Res 2006; 41:150-156.
19. Li S, Wang T, Wang R, Dai X, Chen Q, Li R. Melatonin enhances antinociceptive effects of δ-opioid agonist in mice. Brain Res 2005; 1043:132-138.
20. Golombek DA, Pevet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev 1996; 20:403-412.
21. Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parsons A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 2001; 21:643-655.
22. Ebert E, Hanke W, Wiedemann M, Fernandes de Lima VM. Biphasic effects of melatonin on the propagation of excitation waves in the chicken retina. Neurosci Lett 1999; 268:37-40.